According to Immutep's latest financial reports the company's total assets are $97.6 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-06-30 | $97.6 M | 38.85% |
2022-06-30 | $70.29 M | 14.06% |
2021-06-30 | $61.63 M | 92.48% |
2020-06-30 | $32.02 M | 12.46% |
2019-06-30 | $28.47 M | -18.12% |
2018-06-30 | $34.77 M | 29.41% |
2017-06-30 | $26.87 M | -15.47% |
2016-06-30 | $31.78 M | 33.71% |
2015-06-30 | $23.77 M | -0.53% |
2014-06-30 | $23.89 M | -20.22% |
2013-06-30 | $29.95 M | -29.69% |
2012-06-30 | $42.6 M | -30.87% |
2011-06-30 | $61.63 M | 305.85% |
2010-06-30 | $15.18 M | 656.62% |
2009-06-30 | $2 M | -25.74% |
2008-06-30 | $2.7 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Illumina ILMN | $10.11 B | 10,258.89% | ๐บ๐ธ USA |
FibroGen FGEN | $0.42 B | 333.91% | ๐บ๐ธ USA |
HTG Molecular Diagnostics
HTGM | $10.86 M | -88.87% | ๐บ๐ธ USA |